A Prospective Study for the Treatment of Children With Newly Diagnosed LCH Using a Cytarabine Contained Protocol

Condition:   Langerhans Cell Histiocytosis Interventions:   Drug: Prednisone+Cytarabine+vincristine;   Drug: Prednisone+Cytarabine+vincristine+Mercaptopurine;   Drug: Prednisone+vincristine+Mercaptopurine;   Drug: Prednisone+vincristine;   Other: Local therapy Sponsor:   Shanghai Children's Medical Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials